Professor Erika Lietzan testified before the House of Representatives Judiciary Committee on July 27, 2017 in a hearing addressing Antitrust Concerns and the FDA Approval Process.
Testimony to House of Representatives Judiciary Committee – 7/27/17
Professor Lietzan testifies before the U.S. House of Representatives Judiciary Committee